Market Research Report
Global Anti-Malarial Medicines Market 2020-2024
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||711705|
|Published||Content info||120 Pages
Delivery time: 1-2 business days
|Global Anti-Malarial Medicines Market 2020-2024|
|Published: March 27, 2020||Content info: 120 Pages||
Technavio has been monitoring the anti-malarial medicines market and it is poised to grow by $ 310.75 mn during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on anti-malarial medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the strong funding to eradicate malaria, growing incidence of malaria, and robust pipeline and recent drug approvals. In addition, strong funding to eradicate malaria is anticipated to boost the growth of the market as well.
The anti-malarial medicines market analysis include product segments and geographic landscapes.
Technavio's ‘anti-malarial medicines market ’ is segmented as below:
This study identifies enhanced POC diagnostics and biomarkers for malaria as one of the prime reasons driving the anti-malarial medicines market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our anti-malarial medicines market covers the following areas:
Technavio's ‘robust vendor analysis ’ is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-malarial medicines market vendors that include AstraZeneca Plc, Bayer AG, Cipla Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Mylan NV, Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd.. Also, the anti-malarial medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.